Delic Holdings (CSE: DELC) began to breakout big yesterday gaining by 21.43% to a new all-time high of $0.68 per share on strong volume of 393,447 shares. DELC has a low market cap, small float, and just began trading yesterday on the U.S. OTC under the symbol DELCF. DELC already owns very valuable online media assets related to psychedelics and in the upcoming days/weeks we expect DELC to announce multiple major acquisitions of revenue generating psychedelic companies with at least one of them likely to be in the ketamine infusion therapy space with ketamine being America's only federally legal psychedelic! In August 2020, the FDA approved the ketamine derivative esketamine under brand name Spravato for Major Depressive Disorder (MDD). Ketamine itself was first approved by the FDA in 1970 as an anesthetic agent and can be legally used off-label to treat depression.
Entheon Biomedical (CSE: ENBI) gained by 1.96% yesterday to $1.04 per share on huge volume of 1.491 million shares! ENBI is committed to developing and commercializing a portfolio of safe and effective N,N-dimethyltryptamine (DMT) based psychedelic therapeutic products for the purposes of treating addiction and substance use disorders. ENBI is the only publicly traded pure DMT play in the psychedelic space! Google searches for "what is DMT" hit a new all-time high last week both in the U.S. and worldwide!
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has received compensation from ENBI of USD$30,000 cash for a three-month marketing contract. NIA has received compensation from DELC of USD$25,000 cash and expects to receive 150,000 shares of restricted DELC stock for a six-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.